MedTrace Logo

Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients

NCT02039557 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 33

Last updated 2024-10-23

No results posted yet for this study

Summary

This is an observational study that will monitor clinical outcomes of patients who have received a NiCord®/CordIn™ (omidubicel) transplant as part of a GC clinical interventional study and meet the eligibility criteria for this Long Term Follow Up study.

Conditions

  • Patients Transplanted With NiCord/CordIn (Omidubicel)

Interventions

GENETIC

NiCord®/CordIn™ (omidubicel)

Sponsors & Collaborators

  • Gamida Cell ltd

    lead INDUSTRY

Eligibility

Min Age
2 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-01
Primary Completion
2023-06-29
Completion
2023-06-29

Countries

  • United States
  • Netherlands
  • Singapore
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02039557 on ClinicalTrials.gov